Skip to main content
Tessa NewsLink
Paste a health news link, or browse
Latest checks

Source study unconfirmed

Story checked

Testosterone therapy may increase risk of cardiovascular disease in postmenopausal women (opens in a new tab)

medicalxpress.com · 2026-10-20

Short answerEvidenceSource

Short answer

Source study unconfirmed

No confirmed study match.

We couldn’t confidently identify the source study behind this story. This leaves its claims unverified — not disproven.

15 candidate papersExplore the search results

These papers were considered as possible sources, but none could be confirmed as the study behind this story.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

No single source study could be confirmed.

We could not identify a single source study for this article. It may discuss broader research or report findings from a source other than a research paper.

Open claim evidence
3

Search result

Source study unconfirmed.

We could not identify a single source study for this article. It may discuss broader research or report findings from a source other than a research paper.

Source paper

Source layer

The paper behind the story

The source record for this check.

The research anchor for the report.

  • Also referencedpresented as the new finding

    Testosterone therapy and cardiovascular risk in postmenopausal women: a retrospective propensity-matched cohort study

The literature search

15 candidate papers

Papers surfaced in our search

These papers appeared in the search for the story’s source. None was confirmed as a direct match. Inclusion here does not mean a paper supports or contradicts the story, or that its full text was reviewed.

Show 11 more search results
Then inspect each claim

Evidence layer

Claim by claim

What the story asserts. With no source study, there is nothing to check these against.

Claim 1 of 7Not checkedA new study links testosterone therapy in postmenopausal women with a higher risk of incident cardiovascular disease.View evidenceHide evidence

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Claim 2 of 7Not checkedTestosterone therapy is not routinely recommended for postmenopausal women, in part because long-term safety data remain limited, though it is sometimes prescribed off label for low libido.View evidenceHide evidence

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Claim 3 of 7Not checkedThe study used data from the TriNetX US Collaborative Network and included more than 6,300 propensity-matched menopausal women.View evidenceHide evidence

As statedmore than 6,300 propensity-matched menopausal women

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Claim 4 of 7Not checkedPostmenopausal women 45 and older who initiated testosterone therapy were compared with women without testosterone exposure, after a 12-month washout and exclusion of women with prior cardiovascular disease.View evidenceHide evidence

As stated12-month washout; mean follow-up nearly three years

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Claim 5 of 7Not checkedResearchers concluded that testosterone therapy was associated with a significantly increased hazard of incident composite cardiovascular disease compared with no testosterone exposure (3.8% vs. 0.5%; hazard ratio, 8.08; 95% confidence interval, 4.72–13.82).View evidenceHide evidence

As stated3.8% vs. 0.5%; hazard ratio 8.08

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Claim 6 of 7Not checkedThe findings were consistent in sensitivity analyses comparing women receiving testosterone plus hormone therapy with women receiving hormone therapy alone, and absolute event rates were low.View evidenceHide evidence

As statedabsolute event rates were low

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Claim 7 of 7Not checkedThe composite cardiovascular outcome included coronary artery disease, cerebrovascular disease, or heart failure occurring 30 days to five years after the index date.View evidenceHide evidence

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Finally, the search trail

Method layer

No single source study was found.

The search results are available for you to inspect. Without a confirmed source study, they cannot establish whether the story’s claims are supported or contradicted.

Search results

Candidate papers, not confirmed sources.

PubMed, Europe PMC, Crossref · 15 candidate papers

Candidate

Estradiol/Testosterone Ratio as a Predictor of Coronary Artery Disease in Postmenopausal Women: A Useful Tool!

Indian Journal of Cardiovascular Disease in Women · 2021 · Crossref

Source (opens in a new tab)
Candidate

Alterations of oestradiol, testosterone, gonadotrophins and SHBG by type 2 diabetes in postmenopausal women

Practical Diabetes International · 2007 · Crossref

Source (opens in a new tab)

Explore all search results